De Souza EB - Search Results

1

Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites.

Battaglia G, Brooks BP, Kulsakdinun C, De Souza EB. Battaglia G, et al. Among authors: de souza eb. Eur J Pharmacol. 1988 Apr 27;149(1-2):159-63. doi: 10.1016/0014-2999(88)90056-8. Eur J Pharmacol. 1988. PMID: 2899513

2

Characterization of corticotropin-releasing factor receptors in dissociated brain cell cultures.

Kapcala LP, De Souza EB. Kapcala LP, et al. Among authors: de souza eb. Brain Res. 1988 Jul 19;456(1):159-67. doi: 10.1016/0006-8993(88)90357-5. Brain Res. 1988. PMID: 2842000

3

Neurotoxic effect of MDMA on brain serotonin neurons: evidence from neurochemical and radioligand binding studies.

De Souza EB, Battaglia G, Insel TR. De Souza EB, et al. Ann N Y Acad Sci. 1990;600:682-97; discussion 697-8. doi: 10.1111/j.1749-6632.1990.tb16918.x. Ann N Y Acad Sci. 1990. PMID: 1979218 Review.

4

Corticotropin-releasing hormone (CRH) receptors in brain.

De Souza EB, Battaglia G. De Souza EB, et al. Adv Exp Med Biol. 1988;245:123-36. doi: 10.1007/978-1-4899-2064-5_9. Adv Exp Med Biol. 1988. PMID: 2852454

5

The brain corticotropin-releasing factor (CRF) receptor is of lower apparent molecular weight than the CRF receptor in anterior pituitary. Evidence from chemical cross-linking studies.

Grigoriadis DE, De Souza EB. Grigoriadis DE, et al. Among authors: de souza eb. J Biol Chem. 1988 Aug 5;263(22):10927-31. J Biol Chem. 1988. PMID: 2839512

6

Heterogeneity between brain and pituitary corticotropin-releasing factor receptors is due to differential glycosylation.

Grigoriadis DE, De Souza EB. Grigoriadis DE, et al. Among authors: de souza eb. Endocrinology. 1989 Oct;125(4):1877-88. doi: 10.1210/endo-125-4-1877. Endocrinology. 1989. PMID: 2551631

7

Functional corticotropin-releasing factor (CRF) receptors in mouse spleen: evidence from adenylate cyclase studies.

Webster EL, Battaglia G, De Souza EB. Webster EL, et al. Among authors: de souza eb. Peptides. 1989 Mar-Apr;10(2):395-401. doi: 10.1016/0196-9781(89)90049-1. Peptides. 1989. PMID: 2547206

8

3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.

Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB. Insel TR, et al. Among authors: de souza eb. J Pharmacol Exp Ther. 1989 Jun;249(3):713-20. J Pharmacol Exp Ther. 1989. PMID: 2471824

9

3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.

Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB. Battaglia G, et al. Among authors: de souza eb. J Pharmacol Exp Ther. 1987 Sep;242(3):911-6. J Pharmacol Exp Ther. 1987. PMID: 2443644

10

Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.

De Souza EB, Schmidt WK, Kuhar MJ. De Souza EB, et al. J Pharmacol Exp Ther. 1988 Jan;244(1):391-402. J Pharmacol Exp Ther. 1988. PMID: 2826773

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results